Announcements Trials

Browse Landscape

Phase

Status

Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Carcinoma, Hepatocellular 147 Carcinoma, Renal Cell 37 Parkinson Disease 4, Autosomal Dominant Lewy Body 31 Neoplasms 28 Cholangiocarcinoma 26 Endometrial Neoplasms 19 Thyroid Neoplasms 17 Liver Neoplasms 17 Melanoma 15 Stomach Neoplasms 13 Carcinoma, Non-Small-Cell Lung 13 Biliary Tract Neoplasms 13 Recurrence 9 Neoplasm Metastasis 9 Squamous Cell Carcinoma of Head and Neck 8 Ovarian Neoplasms 8 Breast Neoplasms 8 Uterine Cervical Neoplasms 7 Triple Negative Breast Neoplasms 5 Thyroid Carcinoma, Anaplastic 5 Small Cell Lung Carcinoma 5 Neuroendocrine Tumors 5 Esophageal Squamous Cell Carcinoma 5 Colorectal Neoplasms 5 Pancreatic Neoplasms 4 Kidney Neoplasms 4 Carcinoma, Transitional Cell 4 Carcinoma 4 Adenocarcinoma 4 Thyroid Cancer, Papillary 3

Interventions

Mitotane 10 Cisplatin 9 pembrolizumab 7 Doxorubicin 6 Etoposide 5 Specimen Handling 4 Nivolumab 4 Magnetic Resonance Spectroscopy 4 relacorilant 3 cabozantinib 3 Cytoreduction Surgical Procedures 3 sodium thiosulfate 2 cixutumumab 2 cemiplimab 2 camrelizumab 2 apatinib 2 Trastuzumab 2 Suramin 2 Radiotherapy 2 Ipilimumab 2 Dichlorodiphenyldichloroethane 2 Cyclophosphamide 2 tipifarnib 1 pegfilgrastim 1 milademetan 1 lenvatinib 1 iodophenyl metomidate 1 gossypol acetic acid 1 fludarabine phosphate 1 entinostat 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Adrenocortical Carcinoma × lenvatinib × Clear all

NCT05036434 2026-01-23

ACCOMPLISH

National Cancer Center, Korea

Phase 2 Active not recruiting

Adrenocortical Carcinoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡